Dr. David Fardo is a professor, and the inaugural Stephen W. Wyatt Endowed Professor of Public Health. He serves as Affiliate Faculty in the Sanders-Brown Center on Aging and as co-Investigator in the National Institute on Aging (NIA)-funded UK Alzheimer's Disease Research Center (ADRC).
Dr. Fardo is currently the principal investigator of two awards from the NIA, researching genetic risk factors contributing to various neuropathological endophenotypes and multiple neurodegenerative diseases. His currently funded collaborative work ranges from therapeutic targeting of the genes TREM2 and SHIP1 for AD to investigating novel pathogenetic mechanisms for hippocampal sclerosis and risk factors for conversion to mixed dementias.
He has developed several courses across the spectrum of CPH degree programs and offers graduate courses in statistical genetics. He has served in various roles including as an Academic Leadership Academy Fellow and Chair of CPH Faculty Council and the Appointment, Promotion and Tenure Committee at the University of Kentucky.
View PDF
External Link
Work by several researchers within the University of Kentucky’s Sanders-Brown Center on Aging was recently published in the prestigious journal Nature Genetics.
When is Alzheimer’s disease not Alzheimer’s disease?
Like so many of us, Lincoln Shade’s life has been touched by memory loss and the related agonies of dementia.
